Renewed recommendation from Southern Cross Equities biotech analyst and their head of institutional dealing. Charlie Aitken is well followed and usually a good price increase in the days following a recommendation in his daily newsletter. Watching it go up!
Renewed recommendation from Southern Cross Equities biotech...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.5¢ |
Change
-0.005(0.51%) |
Mkt cap ! $1.116B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 96.0¢ | $3.703M | 3.798M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 211659 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 193216 | 22 |
View Market Depth
| Last trade - 14.36pm 26/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |